Impact of Screening for Salivary Gland by Ultrasonography

Background: Ultrasonography is superior to other imaging modalities for detecting salivary gland diseases. However, there have been no reports of the results of salivary gland screening with ultrasonography. In this study, the salivary glands were also observed during thyroid ultrasonography to determine the degree of salivary gland abnormalities detected by ultrasonography. Methods: This study was conducted retrospectively using medical records. It assessed the association between the following abnormal findings detected during thyroid ultrasonography and their final diagnoses: atrophy/swelling, unclear demarcation from surrounding tissues, decreased salivary gland parenchyma echo level, heterogeneity of parenchyma, hypervascularity of salivary gland parenchyma, dilatation of the ducts, and a mass within the gland. Results: Of the 908 patients who underwent thyroid ultrasonography, salivary gland abnormalities were detected in 36 (4.0%) patients. Of the 36 patients with abnormal ultrasonographic findings, 22 underwent further examination. Of the 22 patients, 16 received definitive diagnoses of salivary gland diseases. Salivary gland disorders were considered to be absent in patients with only heterogeneity of the salivary glands observed on ultrasonography. Salivary gland disorders in all patients with further abnormal ultrasonographic findings such as atrophy/swelling, unclear boundary, or hypervascularity in addition to internal heterogeneity were confirmed by further blood examinations and imaging studies. We were able to detect autoimmune sialadenitis such as Sj ögren’s syndrome and IgG4-related sialadenitis by ultrasonography in patients without obvious symptoms. Conclusion: Salivary gland screening during thyroid ultrasonography revealed abnormal findings including Sjögren’s syndrome and IgG4-related sialadenitis in about 4% of the patients. Thus, ultrasonography may also be useful for early detection of autoimmune diseases of salivary glands

Magnetic and thermodynamic properties of Heusler alloys Ni55Mn26Al19

The temperature dependence of magnetization, M(T), specific heat, Cp(T), and thermal expansion, ΔL/L300K(T) were investigated for the Heusler compound Ni55Mn26Al19 with B2 structure. M(T) has a cusp-type anomaly for the antiferromagnetic (AF) transition at the Néel temperature TN = 280 K that is irreversible between the field-cooled and zero-field-cooled processes below Tf ∼ 60 K, which is characteristic of spin glass. Cp(T) also has an anomaly at TN = 280 K. For temperatures T < 280 K, Cp(T) shows no anomaly without indicating any phase transition. These results mean that with decreasing T Ni55Mn26Al19 has a reentrant spin glass below Tf from the AF state. ΔL/L300K(T) shows no discontinuity indicating a structural transition in the range 5 < T < 300 K, i.e., Ni55Mn26Al19 has no martensitic transformation. TN increases proportionally with pressure, P, because of the enhancement of the AF interaction. The value of its initial rate is estimated to be dTNdP= 5.25 K/GPa. Tf also increases proportionally with P with dTfdP= 2.21 K/GPa, and hence magnetic frustration, which promotes the spin glass system, is enhanced under pressurization

Synthesis of the vasoconstrictor peptide endothelin in kidney cells

AbstractThe expression plasmid containing human prepro-endothelin cDNA was constructed and introduced into COS-7 cells. Mature endothelin, consisting of 21 amino acid residues, was secreted into the culture medium of the transfected cells and was also synthesized by non-transfected COS-7 cells. Normal kidney cells derived from other species also synthesized and secreted endothelins. Partial characterization of endothelins produced by kidney cells suggested the existence of new types of endothelin. This is the first report of the vasoconstrictor peptide endothelin being synthesized in kidney cells